supply of - tab anastrazole 1mg , tab aplutamide 60mg , tab bicalutamide 50mg , tab cabozontanib 40 mg , tab capacitabine 500 mg , tab cyclophosphamide 50mg , tab dasatinib 50mg , tab entacavir 0 point 5mg , tab geftinib 250mg , tab hydroxyurea 500mg , tab lenalidomide 5 mg , tab lenvatinib 4 mg , tab letrazole 2 point 5 mg , tab nintedanib 150mg , tab nintedanib 100mg , tab nilotinib 200 mg , tab pomalidomide 2 mg , tab relugolix 120 mg - medicine | quantity - 27883

Indian Army has invited bids for the supply of - tab anastrazole 1mg , tab aplutamide 60mg , tab bicalutamide 50mg , tab cabozontanib 40 mg , tab capacitabine 500 mg , tab cyclophosphamide 50mg , tab dasatinib 50mg , tab entacavir 0 point 5mg , tab geftinib 250mg , tab hydroxyurea 500mg , tab lenalidomide 5 mg , tab lenvatinib 4 mg , tab letrazole 2 point 5 mg , tab nintedanib 150mg , tab nintedanib 100mg , tab nilotinib 200 mg , tab pomalidomide 2 mg , tab relugolix 120 mg - medicine | quantity - 27883. The estimated project cost is ₹0.05 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 15 October 2026, with the technical opening scheduled for 15 October 2026.